Refractive errors are the most common ocular disorders globally, occurring when the eye's structural abnormalities prevent incoming light from focusing precisely on the retina, resulting in blurred vision. Core subtypes include Myopia (nearsightedness), Hyperopia (farsightedness), Astigmatism, and Presbyopia (age-related loss of near focusing ability, onset typically ≥40 years).

Mild to moderate refractive errors can be corrected with spectacles or contact lenses, while surgical correction is the definitive solution for long-term freedom from glasses. China has the largest volume of refractive surgeries in the world, with over 2 million procedures performed annually, and the surgical safety and efficacy are on par with top international centers.

• Laser-Assisted In Situ Keratomileusis (LASIK): A femtosecond laser creates a thin corneal stromal flap, followed by excimer laser ablation to reshape corneal curvature. Suitable for mild to moderate myopia (up to -12.00 D), hyperopia (up to +6.00 D), and astigmatism (up to +6.00 D). Rapid visual recovery (within 24 hours) and long-proven safety profile.
• Small Incision Lenticule Extraction (SMILE / SMILE Pro): Minimally invasive, flap-free procedure. A femtosecond laser creates a refractive lenticule within the corneal stroma, extracted through a 2–4 mm incision. Suitable for myopia (up to -10.00 D) and astigmatism (up to -5.00 D). Reduced dry eye risk and preserved corneal biomechanics.
• Photorefractive Keratectomy (PRK) / LASEK: Surface ablation without flap creation. Suitable for thin corneas, patients at high risk of ocular trauma (military, athletes). Eliminates all flap-related complications with excellent long-term safety.
• Phakic Intraocular Lens (PIOL) Implantation: A corrective synthetic lens is implanted inside the eye without removing the natural lens. Suitable for severe myopia (up to -20.00 D), thin corneas, and patients aged 18–45 years. Reversible and superior visual quality for high refractive errors.
• Refractive Lens Exchange (RLE): The natural lens is removed and replaced with a premium IOL. Suitable for high refractive errors outside laser/PIOL range, presbyopia patients aged ≥40 years, and early lens opacification.

Cataract is the leading cause of reversible blindness worldwide, characterized by opacification of the natural crystalline lens. The global annual incidence is approximately 20 million new cases, with over 10 million cataract surgeries performed annually in China alone.

Core risk factors include aging (onset typically ≥60 years), diabetes, long-term corticosteroid use, ocular trauma, and UV exposure. Symptoms include progressively blurred vision, glare, faded color perception, and in severe cases complete vision loss. Surgery is the only definitive treatment; no medication can reverse cataract progression.

• Phacoemulsification with IOL Implantation: The global gold-standard. A 2–3 mm self-sealing corneal incision is created, the opacified lens is fragmented by ultrasound and aspirated, and a foldable IOL is implanted. Minimally invasive, sutureless in >90% of cases, 10–15 minutes per eye, and rapid recovery (1–3 days).
• Femtosecond Laser-Assisted Cataract Surgery (FLACS): Image-guided precision. A femtosecond laser performs corneal incision, anterior capsulorhexis, and nucleus fragmentation, followed by phacoemulsification and IOL implantation. Higher precision, reduced ultrasonic energy, and better IOL centration. Ideal for complex cataracts and premium IOL candidates.
• Extracapsular Cataract Extraction (ECCE): Conventional procedure for advanced cases. A 10–12 mm scleral incision is made, the dense nucleus is removed intact, and an IOL is implanted with sutures. Reserved for very dense/hypermature cataracts and cases where phacoemulsification is not feasible.

Glaucoma is a group of diseases characterized by progressive optic nerve damage and visual field loss, usually associated with elevated intraocular pressure (IOP). It is the second leading cause of irreversible blindness worldwide, affecting approximately 80 million people globally.

Core subtypes: Primary Open-Angle Glaucoma (POAG, 70% of cases, chronic/asymptomatic), Primary Angle-Closure Glaucoma (PACG, acute or chronic angle closure), Normal-Tension Glaucoma (NTG), Congenital Glaucoma, and Secondary Glaucoma (diabetes, uveitis, trauma). Surgery is indicated when maximum tolerated medical therapy fails to achieve target IOP.

• Minimally Invasive Glaucoma Surgery (MIGS): First-line for mild to moderate POAG. Micro-incision (1–2 mm) procedures enhancing aqueous outflow with minimal trauma. Common modalities: trabecular micro-bypass stents (iStent, Hydrus), GATT, and suprachoroidal shunts. Most can be performed concurrently with cataract surgery.
• Trabeculectomy (Filtering Surgery): Gold-standard for moderate to advanced glaucoma. Creates a new drainage channel to lower IOP. Suitable for advanced POAG/PACG and refractory glaucoma when MIGS fails.
• Glaucoma Drainage Implants (Tube Shunts): Implantation of a tube + plate device to divert aqueous humor. Suitable for refractory glaucoma, neovascular glaucoma, congenital glaucoma, and failed trabeculectomy.
• Laser Surgeries: SLT (first-line adjunctive for POAG), LPI (definitive treatment for PACG), and CPC (for end-stage/refractory glaucoma and painful blind eyes).
• Congenital Glaucoma Surgery: Goniotomy/trabeculotomy are gold-standard for primary congenital glaucoma, with excellent outcomes when performed in early infancy.

Diabetic Retinopathy is a microvascular complication of diabetes, characterized by retinal ischemia, increased vascular permeability, and pathological neovascularization. It is the leading cause of vision loss in working-age adults globally, affecting over 100 million people.

Clinical staging: Non-Proliferative DR (NPDR, early stage with microaneurysms, hemorrhages, hard exudates, macular edema), and Proliferative DR (PDR, advanced stage with neovascularization, vitreous hemorrhage, tractional retinal detachment). Intravitreal anti-VEGF agents are first-line for diabetic macular edema and active PDR; surgery is reserved for advanced complications.

• Pars Plana Vitrectomy (PPV): Minimally invasive microsurgery via 3 small 0.5–0.7 mm incisions. The vitreous gel is removed, traction is relieved, and endolaser is applied. Suitable for non-clearing vitreous hemorrhage, tractional retinal detachment threatening the macula, and severe fibrovascular proliferation.
• Panretinal Photocoagulation (PRP): Laser gold-standard for high-risk PDR. Scattered laser burns reduce retinal oxygen demand and eliminate the stimulus for neovascularization. Suitable for high-risk PDR and severe NPDR with high progression risk.
• Focal/Grid Laser Photocoagulation: Targeted laser to seal leaking microaneurysms and treat diffuse macular edema in NPDR. Used as an adjunct to first-line intravitreal anti-VEGF therapy.

Corneal disorders affect the clear, dome-shaped anterior surface of the eye, which is responsible for ~70% of the eye's total focusing power. Corneal damage, dystrophy, or infection causes opacification, irregular astigmatism, and severe vision loss.

Common subtypes: Keratoconus, Fuchs' Endothelial Dystrophy, infectious keratitis, corneal scarring, bullous keratopathy, and anterior corneal dystrophies. Etiology includes genetic predisposition, ocular trauma, infection (bacterial/viral/fungal), long-term contact lens wear, and prior intraocular surgery. Clinical presentation: blurred vision, eye pain, photophobia, redness, tearing, and corneal opacification.

• Corneal Cross-Linking (CXL): Gold-standard for progressive keratoconus. Riboflavin eye drops + UVA light exposure create new collagen cross-links, increasing corneal stiffness and halting disease progression. Stops progression in >95% of cases and is minimally invasive.
• Corneal Transplantation (Keratoplasty): Definitive treatment for advanced corneal vision loss. Three main types: (1) Penetrating Keratoplasty (PK, full-thickness transplant); (2) Endothelial Keratoplasty (EK, partial-thickness, gold-standard for endothelial disease, with faster recovery and lower rejection risk); (3) Deep Anterior Lamellar Keratoplasty (DALK, partial-thickness, preserves endothelium).
• Phototherapeutic Keratectomy (PTK): Laser surface ablation to remove superficial corneal scar tissue and irregularities, smoothing the corneal surface and restoring vision. Suitable for superficial corneal scars, recurrent corneal erosions, and superficial corneal dystrophies.

Strabismus is a disorder characterized by misalignment of the eyes, where the eyes do not properly align with each other when looking at an object. It affects approximately 2–4% of the population, and early intervention (in childhood) is associated with superior binocular vision outcomes.

Core subtypes: Esotropia (inward turn), Exotropia (outward turn), Hypertropia/Hypotropia (upward/downward turn), and Cyclotropia (torsional misalignment). Strabismus can cause diplopia, amblyopia ("lazy eye"), and psychosocial distress from cosmetic concerns. Surgical correction is the definitive treatment for strabismus that cannot be corrected with glasses, prisms, or vision therapy.

• Strabismus Surgery (Extraocular Muscle Surgery): Adjusts the length, tension, or insertion position of the extraocular muscles to correct misalignment. Core procedures: Recession (weakens an overactive muscle by moving its insertion posteriorly), Resection (strengthens an underactive muscle by resecting a segment), and Transposition (moves the muscle to correct vertical/torsional misalignment). Safe for both children and adults; earlier intervention in childhood yields superior binocular vision outcomes.